Our study evaluated MRD by MFC, which is not as sensitive as deeper qPCR based assays standardly used core binding factor leukemia, NPM1-mutated AML, and acute promyelocytic leukemia. This evidence concerns the gene NPM1 and acute promyelocytic leukemia.